Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

The stocks in the Hong Kong pharmaceutical sector have recently shown an upward trend. As global capital flows positively ...

A recent modification to the contract would have allowed Vaxart to invoice BARDA for the remaining $230 million or so for ...

The platform can be harnessed for TB, potentially improving protection and durability of immunity in a way that traditional ...

U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

As global capital reassesses the investment value of innovative Chinese companies, the development of innovative vaccines in ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

A $590 million contract awarded to Moderna by the U.S. government to aid in vaccine development for bird flu is being ...

A new vaccine that boosts immunity against tuberculosis (TB) has been shown to be effective in pioneering pre-clinical trials.

We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to ...

A new mRNA vaccine against tuberculosis (TB) is showing favorable results in preclinical trials. With only one currently ...